The Patent Finder

Encore Health, LLC

Also on record
Records under this name other than the patents Encore Health, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Encore Health, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,795,706Methods of Treating Ocular Diseases Using Derivatives of Lipoic Acid
Lapsed on the fee record
Ended Aug 5, 2026 · Medium confidence
Lapsed on the fee recordEnded Aug 5, 2026Medium confidence
US 8,697,109Caged mercaptan and seleno-mercaptan compounds and methods of using them
Lapsed on the fee record
Ended Apr 15, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2026USPTO record
US 7,914,815Method for delivery of pharmaceuticals for treating or preventing presbyopia
Term ended
Term ended Mar 5, 2026 · USPTO record
Term endedTerm ended Mar 5, 2026USPTO record
US 7,935,332Presbyopia treatment by lens alteration
Formerly held
Term ended
Term ended Mar 22, 2025 · USPTO record
Term endedTerm ended Mar 22, 2025USPTO record
US 9,567,314Dithiol Compounds, Derivatives, and Uses Therefor
Lapsed on the fee record
Ended Feb 14, 2025 · High confidence
Lapsed on the fee recordEnded Feb 14, 2025High confidence
US 9,517,225Low dose lipoic acid pharmaceutical compositions and methods
Lapsed on the fee record
Ended Dec 13, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 13, 2024USPTO record
US 9,284,305Methods of Treating Ocular Diseases Using Derivatives of Lipoic Acid
Lapsed on the fee record
Ended Mar 15, 2024 · Medium confidence
Lapsed on the fee recordEnded Mar 15, 2024Medium confidence
US 8,647,612Dithiol compounds, derivatives, and treatment of presbyopia
Term ended
Term ended Jun 3, 2023 · USPTO record
Term endedTerm ended Jun 3, 2023USPTO record
US 6,923,955Presbyopia treatment by lens alteration
Term ended
Term ended Nov 13, 2022 · USPTO record
Term endedTerm ended Nov 13, 2022USPTO record
US 8,747,829Presbyopia treatment by lens alteration of disulfide bonds and reduction
Lapsed on the fee record
Ended Jun 10, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 10, 2022USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited